Clinical Trials Logo

Filter by:
NCT ID: NCT04028674 Active, not recruiting - Clinical trials for Bilateral Vocal Fold Paralysis (BVFP)

Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx

Start date: January 14, 2021
Phase: N/A
Study type: Interventional

The primary purpose of this project is to evaluate the safety of new treatment termed bilateral laryngeal pacing to improve treatment outcomes in patients with bilateral vocal fold paralysis (BVFP) (Aim 1). Outcome measures related to voice and ventilation will also provide initial insights into the efficacy of bilateral (Aim 2) and unilateral (Aim 3) stimulation of the implanted device to improve treatment outcomes in patients with BVFP.

NCT ID: NCT04027972 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Pharmacokinetics of Neostigmine and Glycopyrrolate

Start date: March 9, 2020
Phase: Early Phase 1
Study type: Interventional

A group of 6 able-bodied healthy volunteers will receive Neostigmine (NEO) and Glycopyrrolate (GLY) intravenously and via 2 methods of Iontophoresis (ION): one-patch and two-patch administration, with subsequent blood draws over 1 hour in order to measure the pharmacokinetic behavior of the drugs in-vivo.

NCT ID: NCT04027595 Active, not recruiting - Clinical trials for Posterior Capsule Opacification Obscuring Vision

Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists

Start date: September 17, 2019
Phase:
Study type: Observational

The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.

NCT ID: NCT04027335 Active, not recruiting - Fecal Incontinence Clinical Trials

Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence

Start date: August 27, 2019
Phase: N/A
Study type: Interventional

Pilot study to understand the impact of a digital health system, including a phone app and a vaginal probe to treat fecal incontinence in women

NCT ID: NCT04027023 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Start date: October 30, 2019
Phase: Phase 4
Study type: Interventional

This phase IV study is a prospective open-label multi-center study to investigate the effect of a temporary individualized poly-pharmaceutical De-escalation treatment with the target to regenerate ß-cell function over 12 weeks on the disease stage and glycemic control in patients with type 2 diabetes. This is an uncontrolled pilot study to collect data for later confirmatory trials.

NCT ID: NCT04026867 Active, not recruiting - Hepatitis C Clinical Trials

The DETECT HCV Linkage to Care Trial

DETECT HCV
Start date: November 20, 2019
Phase: N/A
Study type: Interventional

This aim of the DETECT HCV linkage trial compares two linkage to care intervention strategies among (1) newly diagnosed HCV positive patients from the emergency department (ED) and (2) those patients who present to the ED with untreated active HCV. Patients who are positive for HCV and agree to be part of the study will be randomized to either clinician referral alone or clinician referral plus a linkage navigator.

NCT ID: NCT04026412 Active, not recruiting - Clinical trials for Non-Small Cell Lung Cancer (NSCLC)

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

CheckMate73L
Start date: October 8, 2019
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to compare the effectiveness of nivolumab plus concurrent chemoradiotherapy (CCRT) followed by nivolumab plus ipilimumab vs CCRT followed by durvalumab in participants with untreated Locally Advanced Non-small Cell Lung Cancer (LA NSCLC).

NCT ID: NCT04026178 Active, not recruiting - Clinical trials for Generalized Lipodystrophy

Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy

Start date: November 14, 2018
Phase: Phase 4
Study type: Interventional

MYALEPTâ„¢ (metreleptin) has been approved as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy (MYALEPT Prescribing Information). This study is a multicenter, open-label, Phase 4 trial to provide an assessment of the immunogenicity associated with metreleptin and of any major potential risks due to development of antibodies to metreleptin. The study is being conducted to comply with a postmarketing requirement.

NCT ID: NCT04025879 Active, not recruiting - Clinical trials for Carcinoma, Non-Small-Cell Lung

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

Start date: November 5, 2019
Phase: Phase 3
Study type: Interventional

The main purpose of the study is to examine if periadjuvant (neoadjuvant, then adjuvant) immunotherapy will prolong event free survival in participants with early stage non-small cell lung cancer.

NCT ID: NCT04025229 Active, not recruiting - Endometrial Cancer Clinical Trials

High Intensity Interval Training in Endometrial Cancer

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

This interventional trial recruits women with endometrial cancer to participate in high intensity interval training (HIIT) prior to their standard of care surgery. The study will evaluate tissue and blood to determine if HIIT training has anti-cancer effects. P